Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
语言
全文检索
题名
作者
主题
索引号
ISBN/ISSN
标签
检索
高级检索
Treatment of Metastatic Medull...
引用
发送短信
推荐此
打印
导出纪录
导出到 RefWorks
导出到 EndNoteWeb
导出到 EndNote
Permanent link
Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
书目详细资料
Main Authors:
Jr, W
,
Robinson, BG
,
Gagel, R
,
Dralle, H
,
Fagin, J
,
Santoro, M
,
Baudin, E
,
Elisei, R
,
Jarzab, B
,
Vasselli, JR
,
Read, J
,
Langmuir, P
,
Ryan, A
,
Schlumberger, M
格式:
Journal article
出版:
2012
持有资料
实物特征
相似书籍
职员浏览
相似书籍
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
由: Wells, SA, et al.
出版: (2012)
Reply to J.-F. Chatal et al.
由: Wells Jr, SA, et al.
出版: (2012)
Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
由: Nils Degrauwe, et al.
出版: (2012-06-01)
Calcitonin receptor expression in medullary thyroid carcinoma
由: Virginia Cappagli, et al.
出版: (2017-09-01)
Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer
由: Ecem Bostan, et al.
出版: (2022-09-01)